{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T02:04:47Z","timestamp":1789524287905,"version":"build-2803163510"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,23]],"date-time":"2020-11-23T00:00:00Z","timestamp":1606089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,11,23]],"date-time":"2020-11-23T00:00:00Z","timestamp":1606089600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["F32HL154681"],"award-info":[{"award-number":["F32HL154681"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["R38HL143615"],"award-info":[{"award-number":["R38HL143615"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["1R01AR066629-01A1"],"award-info":[{"award-number":["1R01AR066629-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Marfan syndrome (MFS) is a connective tissue disorder caused by mutations in the <jats:italic>FBN1<\/jats:italic> gene that produces wide disease phenotypic variability. The lack of ample genotype\u2013phenotype correlation hinders translational study development aimed at improving disease prognosis. In response to this need, an induced pluripotent stem cell (iPSC) disease model has been used to test patient-specific cells by a proteomic approach. This model has the potential to risk stratify patients to make clinical decisions, including timing for surgical treatment. The regional propensity for aneurysm formation in MFS may be related to distinct smooth muscle cell (SMC) embryologic lineages. Thus, peripheral blood mononuclear cell (PBMC)-derived induced pluripotent stem cells (iPSC) were differentiated into lateral mesoderm (LM, aortic root) and neural crest (NC, ascending aorta\/transverse arch) SMC lineages to model MFS aortic pathology. Isobaric Tags for Relative and Absolute Quantitation (iTRAQ) proteomic analysis by tandem mass spectrometry was applied to profile LM and NC iPSC SMCs from four MFS patients and two healthy controls. Analysis revealed 45 proteins with lineage-dependent expression in MFS patients, many of which were specific to diseased samples. Single protein-level data from both iPSC SMCs and primary MFS aortic root aneurysm tissue confirmed elevated integrin \u03b1V and reduced MRC2 in clinical disease specimens, validating the iPSC iTRAQ findings. Functionally, iPSC SMCs exhibited defective adhesion to a variety of extracellular matrix proteins, especially laminin-1 and fibronectin, suggesting altered cytoskeleton dynamics. This study defines the aortic embryologic origin-specific proteome in a validated iPSC SMC model to identify novel protein markers associated with MFS aneurysm phenotype. Translating iPSC findings into clinical aortic aneurysm tissue samples highlights the potential for iPSC-based methods to model MFS disease for mechanistic studies and therapeutic discovery in vitro.<\/jats:p>","DOI":"10.1038\/s41598-020-77274-w","type":"journal-article","created":{"date-parts":[[2020,11,23]],"date-time":"2020-11-23T11:14:02Z","timestamp":1606130042000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Quantitative proteomics reveal lineage-specific protein profiles in iPSC-derived Marfan syndrome smooth muscle cells"],"prefix":"10.1038","volume":"10","author":[{"given":"Cristiana","family":"Iosef","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert J.","family":"Pedroza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason Z.","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex R.","family":"Dalal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamoru","family":"Arakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Tashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiffany K.","family":"Koyano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grayson","family":"Burdon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha M. P.","family":"Churovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua O.","family":"Orrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchel","family":"Pariani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Fischbein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,23]]},"reference":[{"key":"77274_CR1","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.gene.2016.07.033","volume":"591","author":"LY Sakai","year":"2016","unstructured":"Sakai, L. Y., Keene, D. R., Renard, M. & De Backer, J. FBN1: The disease-causing gene for Marfan syndrome and other genetic disorders. Gene 591, 279\u2013291 (2016).","journal-title":"Gene"},{"key":"77274_CR2","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1016\/S0140-6736(05)67789-6","volume":"366","author":"DP Judge","year":"2005","unstructured":"Judge, D. P. & Dietz, H. C. Marfan\u2019s syndrome. Lancet 366, 1965\u20131976 (2005).","journal-title":"Lancet"},{"key":"77274_CR3","doi-asserted-by":"publisher","first-page":"595","DOI":"10.21037\/acs.2017.10.04","volume":"6","author":"RE Pyeritz","year":"2017","unstructured":"Pyeritz, R. E. Etiology and pathogenesis of the Marfan syndrome: current understanding. Ann. Cardiothorac. Surg. 6, 595\u2013598 (2017).","journal-title":"Ann. Cardiothorac. Surg."},{"key":"77274_CR4","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/ng1116","volume":"33","author":"ER Neptune","year":"2003","unstructured":"Neptune, E. R. et al. Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome. Nat. Genet. 33, 407\u2013411 (2003).","journal-title":"Nat. Genet."},{"key":"77274_CR5","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1126\/science.1124287","volume":"312","author":"JP Habashi","year":"2006","unstructured":"Habashi, J. P. et al. Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science 312, 117\u2013121 (2006).","journal-title":"Science"},{"key":"77274_CR6","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1161\/ATVBAHA.114.305150","volume":"35","author":"JR Cook","year":"2015","unstructured":"Cook, J. R. et al. Dimorphic effects of transforming growth factor-\u03b2 signaling during aortic aneurysm progression in mice suggest a combinatorial therapy for Marfan syndrome. Arterioscler. Thromb. Vasc. Biol. 35, 911\u2013917 (2015).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"77274_CR7","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1038\/s41436-018-0399-4","volume":"21","author":"RE Pyeritz","year":"2019","unstructured":"Pyeritz, R. E. Marfan syndrome: improved clinical history results in expanded natural history. Genet. Med. 21, 1683\u20131690 (2019).","journal-title":"Genet. Med."},{"key":"77274_CR8","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1161\/ATVBAHA.117.309599","volume":"37","author":"H Sawada","year":"2017","unstructured":"Sawada, H., Rateri, D. L., Moorleghen, J. J., Majesky, M. W. & Daugherty, A. Smooth muscle cells derived from second heart field and cardiac neural crest reside in spatially distinct domains in the media of the ascending aorta-brief report. Arterioscler. Thromb. Vasc. Biol. 37, 1722\u20131726 (2017).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"77274_CR9","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1007\/s00018-013-1554-3","volume":"71","author":"S Sinha","year":"2014","unstructured":"Sinha, S., Iyer, D. & Granata, A. Embryonic origins of human vascular smooth muscle cells: implications for in vitro modeling and clinical application. Cell. Mol. Life Sci. 71, 2271\u20132288 (2014).","journal-title":"Cell. Mol. Life Sci."},{"key":"77274_CR10","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/nbt.2107","volume":"30","author":"C Cheung","year":"2012","unstructured":"Cheung, C., Bernardo, A. S., Trotter, M. W. B., Pedersen, R. A. & Sinha, S. Generation of human vascular smooth muscle subtypes provides insight into embryological origin-dependent disease susceptibility. Nat. Biotechnol. 30, 165\u2013173 (2012).","journal-title":"Nat. Biotechnol."},{"key":"77274_CR11","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/ng.3723","volume":"49","author":"A Granata","year":"2017","unstructured":"Granata, A. et al. An iPSC-derived vascular model of Marfan syndrome identifies key mediators of smooth muscle cell death. Nat. Genet. 49, 97\u2013109 (2017).","journal-title":"Nat. Genet."},{"key":"77274_CR12","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1002\/sctm.17-0004","volume":"6","author":"MS Collado","year":"2017","unstructured":"Collado, M. S. et al. Exposure of induced pluripotent stem cell-derived vascular endothelial and smooth muscle cells in coculture to hemodynamics induces primary vascular cell-like phenotypes. Stem Cells Transl. Med. 6, 1673\u20131683 (2017).","journal-title":"Stem Cells Transl. Med."},{"key":"77274_CR13","doi-asserted-by":"publisher","first-page":"101690","DOI":"10.1016\/j.scr.2019.101690","volume":"42","author":"B Ma","year":"2020","unstructured":"Ma, B. et al. Generation of a human induced pluripotent stem cell line (NCCDFWi001-A) from a Marfan syndrome patient carrying two FBN1 variants (c.2613A > C and c.684_736 + 4del). Stem Cell Res. 42, 101690 (2020).","journal-title":"Stem Cell Res."},{"key":"77274_CR14","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","volume":"126","author":"K Takahashi","year":"2006","unstructured":"Takahashi, K. & Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663\u2013676 (2006).","journal-title":"Cell"},{"key":"77274_CR15","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/nature05934","volume":"448","author":"K Okita","year":"2007","unstructured":"Okita, K., Ichisaka, T. & Yamanaka, S. Generation of germline-competent induced pluripotent stem cells. Nature 448, 313\u2013317 (2007).","journal-title":"Nature"},{"key":"77274_CR16","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/nmeth.1591","volume":"8","author":"K Okita","year":"2011","unstructured":"Okita, K. et al. A more efficient method to generate integration-free human iPS cells. Nat. Methods 8, 409\u2013412 (2011).","journal-title":"Nat. Methods"},{"key":"77274_CR17","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1002\/stem.1293","volume":"31","author":"K Okita","year":"2013","unstructured":"Okita, K. et al. An efficient nonviral method to generate integration-free human-induced pluripotent stem cells from cord blood and peripheral blood cells. Stem Cells 31, 458\u2013466 (2013).","journal-title":"Stem Cells"},{"key":"77274_CR18","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/cr.2012.157","volume":"23","author":"J Jiang","year":"2013","unstructured":"Jiang, J. et al. Zscan4 promotes genomic stability during reprogramming and dramatically improves the quality of iPS cells as demonstrated by tetraploid complementation. Cell Res. 23, 92\u2013106 (2013).","journal-title":"Cell Res."},{"key":"77274_CR19","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.stem.2016.11.005","volume":"20","author":"I Carcamo-Orive","year":"2017","unstructured":"Carcamo-Orive, I. et al. Analysis of transcriptional variability in a large human iPSC library reveals genetic and non-genetic determinants of heterogeneity. Cell Stem Cell 20, 518-532.e9 (2017).","journal-title":"Cell Stem Cell"},{"key":"77274_CR20","doi-asserted-by":"publisher","first-page":"14234","DOI":"10.1073\/pnas.1103509108","volume":"108","author":"H Ban","year":"2011","unstructured":"Ban, H. et al. Efficient generation of transgene-free human induced pluripotent stem cells (iPSCs) by temperature-sensitive Sendai virus vectors. Proc. Natl. Acad. Sci. USA 108, 14234\u201314239 (2011).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"77274_CR21","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/978-3-319-77932-4_36","volume":"1065","author":"G Currie","year":"2018","unstructured":"Currie, G. & Delles, C. Precision medicine and personalized medicine in cardiovascular disease. Adv. Exp. Med. Biol. 1065, 589\u2013605 (2018).","journal-title":"Adv. Exp. Med. Biol."},{"key":"77274_CR22","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/nm.4495","volume":"24","author":"Nature Medicine","year":"2018","unstructured":"Nature Medicine. Taking personalized medicine to heart. Nat. Med. 24, 113\u2013113 (2018).","journal-title":"Nat. Med."},{"key":"77274_CR23","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1038\/nprot.2014.059","volume":"9","author":"C Cheung","year":"2014","unstructured":"Cheung, C., Bernardo, A. S., Pedersen, R. A. & Sinha, S. Directed differentiation of embryonic origin-specific vascular smooth muscle subtypes from human pluripotent stem cells. Nat. Protoc. 9, 929\u2013938 (2014).","journal-title":"Nat. Protoc."},{"key":"77274_CR24","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/cr.2012.11","volume":"22","author":"A Achilleos","year":"2012","unstructured":"Achilleos, A. & Trainor, P. A. Neural crest stem cells: discovery, properties and potential for therapy. Cell Res. 22, 288\u2013304 (2012).","journal-title":"Cell Res."},{"key":"77274_CR25","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1002\/dvg.22721","volume":"51","author":"AW Harmon","year":"2013","unstructured":"Harmon, A. W. & Nakano, A. Nkx2-5 lineage tracing visualizes the distribution of second heart field-derived aortic smooth muscle. Genesis 51, 862\u2013869 (2013).","journal-title":"Genesis"},{"key":"77274_CR26","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1161\/ATVBAHA.120.314670","volume":"40","author":"AJ Pedroza","year":"2020","unstructured":"Pedroza, A. J. et al. Single-cell transcriptomic profiling of vascular smooth muscle cell phenotype modulation in marfan syndrome aortic aneurysm. Arterioscler. Thromb. Vasc. Biol. 40, 2195\u20132211 (2020).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"77274_CR27","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.matbio.2014.11.001","volume":"41","author":"OV Sazonova","year":"2015","unstructured":"Sazonova, O. V. et al. Extracellular matrix presentation modulates vascular smooth muscle cell mechanotransduction. Matrix Biol. 41, 36\u201343 (2015).","journal-title":"Matrix Biol."},{"key":"77274_CR28","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.atherosclerosis.2015.10.006","volume":"243","author":"MA Dale","year":"2015","unstructured":"Dale, M. A. et al. Background differences in baseline and stimulated MMP levels influence abdominal aortic aneurysm susceptibility. Atherosclerosis 243, 621\u2013629 (2015).","journal-title":"Atherosclerosis"},{"key":"77274_CR29","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.vph.2018.10.002","volume":"116","author":"MM Blascke de Mello","year":"2019","unstructured":"Blascke de Mello, M. M., Parente, J. M., Schulz, R. & Castro, M. M. Matrix metalloproteinase (MMP)-2 activation by oxidative stress decreases aortic calponin-1 levels during hypertrophic remodeling in early hypertension. Vascul. Pharmacol. 116, 36\u201344 (2019).","journal-title":"Vascul. Pharmacol."},{"key":"77274_CR30","doi-asserted-by":"publisher","first-page":"e0186603","DOI":"10.1371\/journal.pone.0186603","volume":"12","author":"M Dale","year":"2017","unstructured":"Dale, M. et al. Premature aortic smooth muscle cell differentiation contributes to matrix dysregulation in Marfan Syndrome. PLoS ONE 12, e0186603 (2017).","journal-title":"PLoS ONE"},{"key":"77274_CR31","doi-asserted-by":"publisher","first-page":"e92","DOI":"10.1161\/CIRCRESAHA.112.268268","volume":"110","author":"W Xiong","year":"2012","unstructured":"Xiong, W., Meisinger, T., Knispel, R., Worth, J. M. & Baxter, B. T. MMP-2 regulates Erk1\/2 phosphorylation and aortic dilatation in Marfan syndrome. Circ. Res. 110, e92\u2013e101 (2012).","journal-title":"Circ. Res."},{"key":"77274_CR32","doi-asserted-by":"publisher","first-page":"e92660","DOI":"10.1371\/journal.pone.0092660","volume":"9","author":"MG Rohani","year":"2014","unstructured":"Rohani, M. G. et al. uPARAP function in cutaneous wound repair. PLoS ONE 9, e92660 (2014).","journal-title":"PLoS ONE"},{"key":"77274_CR33","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1038\/sj.embor.embor882","volume":"4","author":"L East","year":"2003","unstructured":"East, L. et al. A targeted deletion in the endocytic receptor gene Endo180 results in a defect in collagen uptake. EMBO Rep. 4, 710\u2013716 (2003).","journal-title":"EMBO Rep."},{"key":"77274_CR34","doi-asserted-by":"publisher","first-page":"10230","DOI":"10.1158\/0008-5472.CAN-06-3496","volume":"67","author":"D Wienke","year":"2007","unstructured":"Wienke, D. et al. The collagen receptor Endo180 (CD280) Is expressed on basal-like breast tumor cells and promotes tumor growth in vivo. Cancer Res. 67, 10230\u201310240 (2007).","journal-title":"Cancer Res."},{"key":"77274_CR35","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1111\/jcmm.14921","volume":"24","author":"AJ Pedroza","year":"2020","unstructured":"Pedroza, A. J. et al. Divergent effects of canonical and non-canonical TGF-\u03b2 signalling on mixed contractile-synthetic smooth muscle cell phenotype in human Marfan syndrome aortic root aneurysms. J. Cell Mol. Med. 24, 2369\u20132383 (2020).","journal-title":"J. Cell Mol. Med."},{"key":"77274_CR36","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1161\/ATVBAHA.114.304412","volume":"35","author":"E Crosas-Molist","year":"2015","unstructured":"Crosas-Molist, E. et al. Vascular smooth muscle cell phenotypic changes in patients with Marfan syndrome. Arterioscler. Thromb. Vasc. Biol. 35, 960\u2013972 (2015).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"77274_CR37","doi-asserted-by":"publisher","first-page":"34605","DOI":"10.1074\/jbc.M303159200","volume":"278","author":"DV Bax","year":"2003","unstructured":"Bax, D. V. et al. Cell adhesion to fibrillin-1 molecules and microfibrils is mediated by alpha 5 beta 1 and alpha v beta 3 integrins. J. Biol. Chem. 278, 34605\u201334616 (2003).","journal-title":"J. Biol. Chem."},{"key":"77274_CR38","doi-asserted-by":"publisher","first-page":"3901","DOI":"10.1242\/jcs.03098","volume":"119","author":"JD Humphries","year":"2006","unstructured":"Humphries, J. D., Byron, A. & Humphries, M. J. INTEGRIN LIGANDS. J. Cell Sci. 119, 3901\u20133903 (2006).","journal-title":"J. Cell Sci."},{"key":"77274_CR39","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-1-61779-166-6_1","volume":"757","author":"A Chigaev","year":"2012","unstructured":"Chigaev, A. & Sklar, L. A. Overview: assays for studying integrin-dependent cell adhesion. Methods Mol. Biol. 757, 3\u201314 (2012).","journal-title":"Methods Mol. Biol."},{"key":"77274_CR40","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1161\/01.RES.88.1.37","volume":"88","author":"TE Bunton","year":"2001","unstructured":"Bunton, T. E. et al. Phenotypic alteration of vascular smooth muscle cells precedes elastolysis in a mouse model of Marfan syndrome. Circ. Res. 88, 37\u201343 (2001).","journal-title":"Circ. Res."},{"key":"77274_CR41","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1242\/jcs.113.6.1021","volume":"113","author":"H Sheikh","year":"2000","unstructured":"Sheikh, H., Yarwood, H., Ashworth, A. & Isacke, C. M. Endo180, an endocytic recycling glycoprotein related to the macrophage mannose receptor is expressed on fibroblasts, endothelial cells and macrophages and functions as a lectin receptor. J. Cell Sci. 113, 1021\u20131032 (2000).","journal-title":"J. Cell Sci."},{"key":"77274_CR42","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.ejca.2008.11.023","volume":"45","author":"G Kogianni","year":"2009","unstructured":"Kogianni, G., Walker, M. M., Waxman, J. & Sturge, J. Endo180 expression with cofunctional partners MT1-MMP and uPAR-uPA is correlated with prostate cancer progression. Eur. J. Cancer 45, 685\u2013693 (2009).","journal-title":"Eur. J. Cancer"},{"key":"77274_CR43","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1055\/s-0038-1633999","volume":"44","author":"C Baumgartner","year":"2005","unstructured":"Baumgartner, C., M\u00e1ty\u00e1s, G., Steinmann, B. & Baumgartner, D. Marfan syndrome\u2014a diagnostic challenge caused by phenotypic and genetic heterogeneity. Methods Inf. Med. 44, 487\u2013497 (2005).","journal-title":"Methods Inf. Med."},{"key":"77274_CR44","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.jtcvs.2006.07.001","volume":"132","author":"D Baumgartner","year":"2006","unstructured":"Baumgartner, D. et al. Different patterns of aortic wall elasticity in patients with Marfan syndrome: a noninvasive follow-up study. J. Thorac. Cardiovasc. Surg. 132, 811\u2013819 (2006).","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"77274_CR45","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1172\/JCI123547","volume":"129","author":"EG MacFarlane","year":"2019","unstructured":"MacFarlane, E. G. et al. Lineage-specific events underlie aortic root aneurysm pathogenesis in Loeys-Dietz syndrome. J. Clin. Investig. 129, 659\u2013675 (2019).","journal-title":"J. Clin. Investig."},{"key":"77274_CR46","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1242\/jcs.166157","volume":"128","author":"H Taylor-Weiner","year":"2015","unstructured":"Taylor-Weiner, H., Ravi, N. & Engler, A. J. Traction forces mediated by integrin signaling are necessary for definitive endoderm specification. J. Cell. Sci. 128, 1961\u20131968 (2015).","journal-title":"J. Cell. Sci."},{"key":"77274_CR47","doi-asserted-by":"publisher","first-page":"H1112","DOI":"10.1152\/ajpheart.00089.2018","volume":"315","author":"SJ Parker","year":"2018","unstructured":"Parker, S. J. et al. Proteomics reveals Rictor as a noncanonical TGF-\u03b2 signaling target during aneurysm progression in Marfan mice. Am. J. Physiol. Heart Circ. Physiol. 315, H1112\u2013H1126 (2018).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"77274_CR48","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.freeradbiomed.2018.02.023","volume":"118","author":"F Jim\u00e9nez-Altay\u00f3","year":"2018","unstructured":"Jim\u00e9nez-Altay\u00f3, F. et al. Redox stress in Marfan syndrome: Dissecting the role of the NADPH oxidase NOX4 in aortic aneurysm. Free Radic. Biol. Med. 118, 44\u201358 (2018).","journal-title":"Free Radic. Biol. Med."},{"key":"77274_CR49","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1161\/CIRCULATIONAHA.108.843516","volume":"120","author":"C Pilop","year":"2009","unstructured":"Pilop, C. et al. Proteomic analysis in aortic media of patients with Marfan syndrome reveals increased activity of calpain 2 in aortic aneurysms. Circulation 120, 983\u2013991 (2009).","journal-title":"Circulation"},{"key":"77274_CR50","doi-asserted-by":"publisher","first-page":"2764","DOI":"10.1093\/hmg\/ddv037","volume":"24","author":"M Aubart","year":"2015","unstructured":"Aubart, M. et al. The clinical presentation of Marfan syndrome is modulated by expression of wild-type FBN1 allele. Hum. Mol. Genet. 24, 2764\u20132770 (2015).","journal-title":"Hum. Mol. Genet."},{"key":"77274_CR51","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1086\/341581","volume":"71","author":"I Schrijver","year":"2002","unstructured":"Schrijver, I. et al. Premature termination mutations in FBN1: distinct effects on differential allelic expression and on protein and clinical phenotypes. Am. J. Hum. Genet. 71, 223\u2013237 (2002).","journal-title":"Am. J. Hum. Genet."},{"key":"77274_CR52","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1002\/humu.10113","volume":"20","author":"PN Robinson","year":"2002","unstructured":"Robinson, P. N. et al. Mutations of FBN1 and genotype-phenotype correlations in Marfan syndrome and related fibrillinopathies. Hum. Mutat. 20, 153\u2013161 (2002).","journal-title":"Hum. Mutat."},{"key":"77274_CR53","doi-asserted-by":"publisher","first-page":"3285","DOI":"10.1093\/eurheartj\/ehv739","volume":"37","author":"R Franken","year":"2016","unstructured":"Franken, R. et al. Genotype impacts survival in Marfan syndrome. Eur. Heart J. 37, 3285\u20133290 (2016).","journal-title":"Eur. Heart J."},{"key":"77274_CR54","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1136\/heartjnl-2016-310631","volume":"103","author":"R Franken","year":"2017","unstructured":"Franken, R. et al. Relationship between fibrillin-1 genotype and severity of cardiovascular involvement in Marfan syndrome. Heart 103, 1795\u20131799 (2017).","journal-title":"Heart"},{"key":"77274_CR55","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1136\/heartjnl-2014-306381","volume":"101","author":"I Luyckx","year":"2015","unstructured":"Luyckx, I. & Loeys, B. L. Curriculum topic: disease of the aorta and trauma to the aorta and heart. The genetic architecture of non-syndromic thoracic aortic aneurysm. Heart 101, 1678\u20131684 (2015).","journal-title":"Heart"},{"key":"77274_CR56","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/nature10145","volume":"473","author":"ME Lindsay","year":"2011","unstructured":"Lindsay, M. E. & Dietz, H. C. Lessons on the pathogenesis of aneurysm from heritable conditions. Nature 473, 308\u2013316 (2011).","journal-title":"Nature"},{"key":"77274_CR57","doi-asserted-by":"publisher","first-page":"348","DOI":"10.2183\/pjab.85.348","volume":"85","author":"N Fusaki","year":"2009","unstructured":"Fusaki, N., Ban, H., Nishiyama, A., Saeki, K. & Hasegawa, M. Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome. Proc. Jpn. Acad. Ser. B Phys. Biol. Sci. 85, 348\u2013362 (2009).","journal-title":"Proc. Jpn. Acad. Ser. B Phys. Biol. Sci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-77274-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-77274-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-77274-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T00:01:23Z","timestamp":1670371283000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-77274-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,23]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["77274"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-77274-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,23]]},"assertion":[{"value":"10 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20392"}}